Jazz Pharmaceuticals PLC at Needham Neuroscience Forum (Virtual) Transcript
Good afternoon, everyone. Welcome to our session with Jazz. It's my pleasure to be hosting the Jazz team with Bruce Cozadd, who is the Chairman and CEO of the company; along with his R&D leadership team. We've got Robert Iannone, who is the Head of Research and Development; Phil Jochelson who's the Head of Neuroscience Development and Joshua Stadelmann, who's the Vice President of neuropsychiatry.
Perhaps I would request Bruce to kick us off with a few opening remarks, and we can take it from there. Before I let you start, Bruce, just for the audience, if you have any questions along the way that you'd like me to ask, please feel free to send it over in the chart. With that, Bruce?
Great, Ami, and thank you for having us today. It's nice to be able to dive into 1 area of our pipeline with a little more specification. Before we get going, I do want to note that no forward-looking statements, and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |